Skip to content
ns in February for the clinical application of new biomedical technologies, stipulating that clini
cal research that involves human trials, including gene editing, stem cells, organ transplants be
tween species and assisted reproductive technologies, must secure the approval of the commission in advance.
Under the draft, which is yet to be adopted, violators may face punishments including fines, revocation of business permits or criminal charges.
The commission this year will complete its revision of an existing r
egulation on ethical inspection of human-related biomedical research that was adopted in 2016.
Authorities are also considering establishing a national ethics co
mmittee that supervises life science technologies and researchers to ensure compliance wi
th ethical standards, Huang Jiefu, former vice-minister of health, told China Daily in an earlier interview.
identify unwarranted certification items for abolition and list all certification items deemed ne
cessary. At the same time, work to establish a pre-commitment qualification system will be intensified.
“The reform of the qualification system is part and parcel of our efforts to build a credit-based society. Without a fully fledg
ed credit-based society, our business environment will not see significant improvements,” Li said.
It was decided at the meeting that the practice of pre-commitment of qualification will be piloted in 13 pro
vinces and municipalities, including Tianjin, Liaoning, Shanghai, Guangdong, Sichuan and Shaanxi, and in five mi
nistries－the Ministry of Public Security, the Ministry of Justice, the Minist
ry of Human Resources and Social Security, the Ministry of Natural Resources and the Ministry of Transport.
on the new science and technology innovation board, which will pilot the registration-based IPO system, according to Xinhua.
To accommodate the progress of reforms and development of the capital market, other modifications have also been made, cov
ering public issuance of securities, securities trading, and the protection of investors’ rights and interests, Xinhua said.
Dong expects the latest version to legitimize registration-based IPO systems not only
on the new board, but also across China’s whole A-share market. “Once the system achieves success on the n
ew board, it should be adopted on other submarkets as soon as possible,” Dong said.
President Xi Jinping announced in November that China will launch the S&T innovation board and pilot the registr
ation-based IPO system. Analysts expect the new board to begin trading around the middle of this year.
“The latest draft is expected to make comprehensive revisions, and it could go a long way
toward restoring public investors’ confidence and modernizing the regulation and governance of the ca
pital market,” said Liu Junhai, director of the Business Law Center at Renmin University of China.
China has released 11.25 million spectra – keys for understanding the properties of celestia
l bodies – acquired by the Large Sky Area Multi-Object Fiber Spectroscopic Telescope to astronomers worldwide.
As the world’s largest spectral survey telescope, LAMOST marks the world’
s first spectral survey project to obtain more than 10 million spectra, which will give
insights into chemical compositions, densities, atmospheres and magnetism of celestial bodies.
Among the data, there are 9.37 million high-quality spectra, twice the total number of other astronomic surveys intern
ationally. There are also 6.36 million stellar spectra, creating the largest stellar parameter catalog in the wor
ld, according to the National Astronomical Observatories of China of the Chinese Academy of Sciences on Friday.
Finished in 2008, LAMOST began regular surveys in 2012. The telescope is located in Natio
nal Astronomical Observatories of China’s Xinglong Observatory, in north China’s Hebei province.